📰 Halberd Daily News
Page 2 - Halberd Daily News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Halberd Daily. Real-time updates on events, politics, business and more.
June 20, 2023
Halberd (OTCMKTS:HALB – Get Rating) is one of 344 public companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare Halberd to similar companies based on the strength of its analyst recommendations, valuation, profitability, risk, earnings, dividends and institutional ownership. Valuation and Earnings This table compares Halberd and its […]
June 17, 2023
Halberd (OTCMKTS:HALB – Get Rating) is one of 348 publicly-traded companies in the “Biotechnology” industry, but how does it contrast to its rivals? We will compare Halberd to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, profitability, earnings, dividends and risk. Earnings & Valuation This table compares Halberd and its […]
June 17, 2023
Halberd (OTCMKTS:HALB – Get Rating) is one of 348 public companies in the “Biotechnology” industry, but how does it compare to its peers? We will compare Halberd to related businesses based on the strength of its dividends, risk, earnings, profitability, analyst recommendations, valuation and institutional ownership. Institutional & Insider Ownership 24.9% of shares of all […]
June 15, 2023
Halberd (OTCMKTS:HALB – Get Rating) is one of 379 publicly-traded companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Halberd to similar companies based on the strength of its valuation, analyst recommendations, profitability, risk, institutional ownership, dividends and earnings. Analyst Ratings This is a breakdown of current ratings […]
June 9, 2023
Halberd (OTCMKTS:HALB – Get Rating) is one of 343 public companies in the “Biotechnology” industry, but how does it weigh in compared to its peers? We will compare Halberd to similar companies based on the strength of its valuation, earnings, profitability, risk, analyst recommendations, institutional ownership and dividends. Insider & Institutional Ownership 22.3% of shares […]
June 7, 2023
Halberd (OTCMKTS:HALB – Get Rating) is one of 361 public companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare Halberd to related companies based on the strength of its analyst recommendations, profitability, earnings, dividends, institutional ownership, valuation and risk. Institutional and Insider Ownership 26.0% of shares of all […]
May 2, 2023
Halberd Co. (OTCMKTS:HALB – Get Rating) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 88,700 shares, an increase of 14.0% from the March 31st total of 77,800 shares. Based on an average daily volume of 3,158,700 shares, the days-to-cover […]
May 2, 2023
Halberd Co. (OTCMKTS:HALB – Get Rating) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 88,700 shares, an increase of 14.0% from the March 31st total of 77,800 shares. Based on an average daily volume of 3,158,700 shares, the days-to-cover […]